Cargando…
Comprehensive Evaluation of Psychotic Features and Their Clinical Correlates in Early Parkinson’s Disease
BACKGROUND: Some reports suggest that psychotic features may occur in the early stages of Parkinson’s disease (PD), but sensitive tools have not been utilized. OBJECTIVE: The aim was to evaluate the presence of psychotic symptoms using detailed scales and to assess the association with clinical char...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10657660/ https://www.ncbi.nlm.nih.gov/pubmed/37840503 http://dx.doi.org/10.3233/JPD-230056 |
_version_ | 1785148185069486080 |
---|---|
author | Pachi, Ioanna Papadopoulos, Vassilis Koros, Christos Simitsi, Athina Maria Bougea, Anastasia Bozi, Maria Papagiannakis, Nikos Soldatos, Rigas Filippos Kolovou, Dimitra Pantes, George Scarmeas, Nikolaos Paraskevas, Georgios Voumvourakis, Konstantinos Papageorgiou, Sokratis G. Kollias, Konstantinos Stefanis, Nikos Stefanis, Leonidas |
author_facet | Pachi, Ioanna Papadopoulos, Vassilis Koros, Christos Simitsi, Athina Maria Bougea, Anastasia Bozi, Maria Papagiannakis, Nikos Soldatos, Rigas Filippos Kolovou, Dimitra Pantes, George Scarmeas, Nikolaos Paraskevas, Georgios Voumvourakis, Konstantinos Papageorgiou, Sokratis G. Kollias, Konstantinos Stefanis, Nikos Stefanis, Leonidas |
author_sort | Pachi, Ioanna |
collection | PubMed |
description | BACKGROUND: Some reports suggest that psychotic features may occur in the early stages of Parkinson’s disease (PD), but sensitive tools have not been utilized. OBJECTIVE: The aim was to evaluate the presence of psychotic symptoms using detailed scales and to assess the association with clinical characteristics. METHODS: Healthy controls and patients within three years of PD onset were recruited. Participants were examined for psychotic symptoms using two different instruments: the Comprehensive Assessment of At-Risk Mental States (CAARMS) and a 10 question PD specific psychosis severity scale (10PDQ). In the PD group, medication use, motor and non-motor symptoms were documented. RESULTS: Based on CAARMS and 10PDQ scales, psychotic features were present in 39% (27/70) of patients and 4% (3/74) of controls. The prevalence of passage hallucinations and illusions was significantly higher in PD compared to the control group. The presence of PD-associated psychotic features was not significantly affected by medication, motor severity or global cognitive status. Higher prevalence of overall non-motor manifestations, REM sleep behavior disorder (RBD) and depressive symptoms was significantly associated with the manifestation of psychotic features in PD [(adjusted OR:1.3; 95% CI:1.1-1.6; p = 0.003), (adjusted OR:1.3; 95% CI:1.0-1.6; p = 0.023), and (adjusted OR:1.2; 95% CI:1.0-1.4;p = 0.026)]. CONCLUSIONS: Psychotic phenomena mainly of minor nature are highly common in early PD. Cumulative non-motor symptoms, RBD and depressive features are associated with the presence of psychotic symptoms in this non-demented, early-stage PD population. More studies are needed to clarify the mechanisms that contribute to the onset of psychotic features in early PD. |
format | Online Article Text |
id | pubmed-10657660 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | IOS Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-106576602023-11-19 Comprehensive Evaluation of Psychotic Features and Their Clinical Correlates in Early Parkinson’s Disease Pachi, Ioanna Papadopoulos, Vassilis Koros, Christos Simitsi, Athina Maria Bougea, Anastasia Bozi, Maria Papagiannakis, Nikos Soldatos, Rigas Filippos Kolovou, Dimitra Pantes, George Scarmeas, Nikolaos Paraskevas, Georgios Voumvourakis, Konstantinos Papageorgiou, Sokratis G. Kollias, Konstantinos Stefanis, Nikos Stefanis, Leonidas J Parkinsons Dis Research Report BACKGROUND: Some reports suggest that psychotic features may occur in the early stages of Parkinson’s disease (PD), but sensitive tools have not been utilized. OBJECTIVE: The aim was to evaluate the presence of psychotic symptoms using detailed scales and to assess the association with clinical characteristics. METHODS: Healthy controls and patients within three years of PD onset were recruited. Participants were examined for psychotic symptoms using two different instruments: the Comprehensive Assessment of At-Risk Mental States (CAARMS) and a 10 question PD specific psychosis severity scale (10PDQ). In the PD group, medication use, motor and non-motor symptoms were documented. RESULTS: Based on CAARMS and 10PDQ scales, psychotic features were present in 39% (27/70) of patients and 4% (3/74) of controls. The prevalence of passage hallucinations and illusions was significantly higher in PD compared to the control group. The presence of PD-associated psychotic features was not significantly affected by medication, motor severity or global cognitive status. Higher prevalence of overall non-motor manifestations, REM sleep behavior disorder (RBD) and depressive symptoms was significantly associated with the manifestation of psychotic features in PD [(adjusted OR:1.3; 95% CI:1.1-1.6; p = 0.003), (adjusted OR:1.3; 95% CI:1.0-1.6; p = 0.023), and (adjusted OR:1.2; 95% CI:1.0-1.4;p = 0.026)]. CONCLUSIONS: Psychotic phenomena mainly of minor nature are highly common in early PD. Cumulative non-motor symptoms, RBD and depressive features are associated with the presence of psychotic symptoms in this non-demented, early-stage PD population. More studies are needed to clarify the mechanisms that contribute to the onset of psychotic features in early PD. IOS Press 2023-11-03 /pmc/articles/PMC10657660/ /pubmed/37840503 http://dx.doi.org/10.3233/JPD-230056 Text en © 2023 – The authors. Published by IOS Press https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial (CC BY-NC 4.0) License (https://creativecommons.org/licenses/by-nc/4.0/) , which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Report Pachi, Ioanna Papadopoulos, Vassilis Koros, Christos Simitsi, Athina Maria Bougea, Anastasia Bozi, Maria Papagiannakis, Nikos Soldatos, Rigas Filippos Kolovou, Dimitra Pantes, George Scarmeas, Nikolaos Paraskevas, Georgios Voumvourakis, Konstantinos Papageorgiou, Sokratis G. Kollias, Konstantinos Stefanis, Nikos Stefanis, Leonidas Comprehensive Evaluation of Psychotic Features and Their Clinical Correlates in Early Parkinson’s Disease |
title | Comprehensive Evaluation of Psychotic Features and Their Clinical Correlates in Early Parkinson’s Disease |
title_full | Comprehensive Evaluation of Psychotic Features and Their Clinical Correlates in Early Parkinson’s Disease |
title_fullStr | Comprehensive Evaluation of Psychotic Features and Their Clinical Correlates in Early Parkinson’s Disease |
title_full_unstemmed | Comprehensive Evaluation of Psychotic Features and Their Clinical Correlates in Early Parkinson’s Disease |
title_short | Comprehensive Evaluation of Psychotic Features and Their Clinical Correlates in Early Parkinson’s Disease |
title_sort | comprehensive evaluation of psychotic features and their clinical correlates in early parkinson’s disease |
topic | Research Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10657660/ https://www.ncbi.nlm.nih.gov/pubmed/37840503 http://dx.doi.org/10.3233/JPD-230056 |
work_keys_str_mv | AT pachiioanna comprehensiveevaluationofpsychoticfeaturesandtheirclinicalcorrelatesinearlyparkinsonsdisease AT papadopoulosvassilis comprehensiveevaluationofpsychoticfeaturesandtheirclinicalcorrelatesinearlyparkinsonsdisease AT koroschristos comprehensiveevaluationofpsychoticfeaturesandtheirclinicalcorrelatesinearlyparkinsonsdisease AT simitsiathinamaria comprehensiveevaluationofpsychoticfeaturesandtheirclinicalcorrelatesinearlyparkinsonsdisease AT bougeaanastasia comprehensiveevaluationofpsychoticfeaturesandtheirclinicalcorrelatesinearlyparkinsonsdisease AT bozimaria comprehensiveevaluationofpsychoticfeaturesandtheirclinicalcorrelatesinearlyparkinsonsdisease AT papagiannakisnikos comprehensiveevaluationofpsychoticfeaturesandtheirclinicalcorrelatesinearlyparkinsonsdisease AT soldatosrigasfilippos comprehensiveevaluationofpsychoticfeaturesandtheirclinicalcorrelatesinearlyparkinsonsdisease AT kolovoudimitra comprehensiveevaluationofpsychoticfeaturesandtheirclinicalcorrelatesinearlyparkinsonsdisease AT pantesgeorge comprehensiveevaluationofpsychoticfeaturesandtheirclinicalcorrelatesinearlyparkinsonsdisease AT scarmeasnikolaos comprehensiveevaluationofpsychoticfeaturesandtheirclinicalcorrelatesinearlyparkinsonsdisease AT paraskevasgeorgios comprehensiveevaluationofpsychoticfeaturesandtheirclinicalcorrelatesinearlyparkinsonsdisease AT voumvourakiskonstantinos comprehensiveevaluationofpsychoticfeaturesandtheirclinicalcorrelatesinearlyparkinsonsdisease AT papageorgiousokratisg comprehensiveevaluationofpsychoticfeaturesandtheirclinicalcorrelatesinearlyparkinsonsdisease AT kolliaskonstantinos comprehensiveevaluationofpsychoticfeaturesandtheirclinicalcorrelatesinearlyparkinsonsdisease AT stefanisnikos comprehensiveevaluationofpsychoticfeaturesandtheirclinicalcorrelatesinearlyparkinsonsdisease AT stefanisleonidas comprehensiveevaluationofpsychoticfeaturesandtheirclinicalcorrelatesinearlyparkinsonsdisease |